A history of one of the most universally adopted medical devices. The condom’s technology has changed substantially across five centuries — linen, animal-gut, vulcanised rubber, latex, polyurethane, polyisoprene — and each shift has connected to a wider history of public health, sexual practice, and contraceptive politics.

Overview

The condom is a barrier device worn on the penis during sexual activity, functioning simultaneously as a contraceptive and as a barrier prophylactic against sexually transmitted infections. It is one of the oldest and most widely adopted medical devices, with documented use across several centuries and continuous industrial production since the 1840s. Its history is bound to the history of contraception, the history of sexually transmitted disease, and the history of public-health regulation.

Pre-modern antecedents

References to penile-covering devices in pre-modern medical literature are scattered and difficult to characterise. Ancient-Egyptian wall art depicting penile-covering objects has been variously interpreted as ritual covering, urethral protection, or some form of prophylactic, with no scholarly consensus. References in the works attributed to Galen of Pergamon (second-century Roman physician) have been similarly read.

In medieval and early-modern Europe, the spread of syphilis from the late fifteenth century (the Naples disease outbreak from 1495 onward) drove interest in barrier devices for prophylaxis. Gabriele Falloppio’s De Morbo Gallico (published posthumously 1564) is the principal sixteenth-century reference, recommending a linen sheath secured with a ribbon as a syphilis preventive. Falloppio’s recommendation is one of the earliest unambiguous European documentations of barrier prophylaxis.

In the seventeenth and eighteenth centuries, animal-membrane devices — most often from sheep caecum or bladder — became available to the European aristocracy. These had the same basic structure as the modern condom and were used for both contraception and disease prophylaxis. The English word condom enters the historical record in this period, though its etymology is disputed: the often-repeated derivation from a physician Dr. Condom in the court of Charles II is not securely established.

Rubber and latex (nineteenth and twentieth centuries)

The decisive technological transformation was rubber vulcanisation. Charles Goodyear’s 1844 patent for the vulcanisation of natural rubber made durable rubber products feasible; Thomas Hancock’s 1843 English patent had achieved a related result. Rubber condoms — initially reusable, vulcanised-rubber sheaths — appeared in the second half of the nineteenth century and constituted a substantial improvement over animal-membrane work in durability and standardisation.

The early twentieth century saw the development of latex (suspension-form rubber) processing, which permitted thinner, more flexible, and single-use products. By the 1920s and 1930s, latex condoms in mass-production form became widely available. Industrial production at scale brought prices down to levels that supported widespread popular use, and the condom became a working part of contraceptive and disease-prevention practice across much of the industrialised world.

The interwar US Comstock Act regime restricted the postal distribution of contraceptive materials; the 1936 Second Circuit ruling United States v. One Package of Japanese Pessaries (86 F.2d 737) effectively ended the contraception ban by holding that contraceptive distribution to physicians was not within the Comstock Act’s scope. Margaret Sanger’s birth-control activism through the 1910s–1950s operated against the Comstock background.

In Catholic-dominant Europe, the contraceptive question remained politically contested. Pope Paul VI’s 1968 encyclical Humanae Vitae affirmed the Catholic prohibition on artificial contraception. The French Loi Neuwirth of 1967 legalised contraception in France, and the rapid expansion of access to oral contraceptives through the 1960s transformed the contraceptive landscape across Western Europe and North America.

Japanese adoption

Western-pattern condoms entered Japan in the Meiji period through medical-supply import channels. Several Japanese-language names operated alongside the loanword form: kenmaku (賢膜), gomu sleeve (ゴムスリーブ), and the eventual katakana kondoomu (コンドーム). The early twentieth century saw the establishment of Japanese-language manufacturers: Ocean Trading Company (1909, the predecessor of Okamoto Industries), Sagami Rubber (1934), and others.

In the postwar period, Japanese-made condoms became internationally known for thinness and quality. Japanese manufacturers’ continuous development of thinner products — culminating in the 0.01 mm and 0.02 mm super-thin grades from the 2000s onward — has been a recognised feature of the international market. The Japanese-domestic distribution and marketing of condoms has been substantial throughout the postwar period.

The Japanese contraceptive market has distinctive features. Oral contraceptives (the pill) were not approved for general use in Japan until 1999, decades after their authorisation in most other industrialised countries; the Viagra (sildenafil) male erectile dysfunction treatment was authorised in 1999, the same year, and the contrast was widely commented on in the popular press as evidence of regulatory gender asymmetry. The late pill availability meant that condoms operated as the principal contraceptive method in Japan for much longer than elsewhere, contributing to the high domestic market for the product.

HIV/AIDS and the prophylaxis turn

The HIV/AIDS pandemic from the early 1980s transformed the condom’s position in public-health discourse. From the mid-1980s, public-health authorities worldwide repositioned the condom as a primary disease-prevention tool — the condoms prevent AIDS messaging was deployed across television, print, and educational media. The repositioning carried the condom from the contraceptive category into the dual-function contraceptive/prophylactic category in mainstream understanding.

In Japan, the 1987 AIDS panic (the public reaction to the first widely-reported domestic AIDS cases) drove the same shift. Condom-and-STI association became part of the standard public-health messaging, and the condom’s social and cultural standing shifted accordingly.

The HIV-driven repositioning had two important consequences. First, it expanded the consumer base for condoms substantially, particularly among populations that had previously relied on other contraceptive methods. Second, it shifted the regulatory and marketing emphasis toward STI-prevention claims, which interacted with subsequent product-development priorities (latex-allergy alternatives, microbial-prevention testing protocols).

Contemporary materials and forms

The contemporary condom market includes several material types alongside standard latex. Polyurethane condoms (introduced commercially from the 1990s) provide a thinner, latex-allergy-compatible alternative; polyisoprene condoms (synthetic rubber, latex-allergy-compatible with rubber-like properties) emerged in the 2000s. The female condom (femidom, internal condom) became available from the 1990s, with the Female Health Company’s FC1 product (1993) and the successor FC2 (2009) as the principal commercial offerings.

Specialised product variants — textured, ultra-thin, larger or smaller sizes, integrated lubricants, flavoured products for oral use — have expanded substantially since the 1990s. The Japanese super-thin product lines (Sagami 0.02, Okamoto 0.02 and 0.01) remain notable for thinness internationally.

Public-health and regulatory context

Condom availability and pricing have substantial public-health effects. The role of the condom in the suppression of HIV transmission across the late twentieth and early twenty-first centuries has been one of the major public-health success cases of recent decades. National policies on condom distribution (free distribution in some jurisdictions, retail-only distribution in others, restrictions on distribution in some religious contexts) continue to vary substantially.

The relationship between condom use and contraceptive policy is complex. In jurisdictions with high oral-contraceptive use, condom use is often concentrated in dual-method situations (combined with oral contraception for STI prevention) and in casual-encounter situations. In jurisdictions with limited oral-contraceptive availability, condoms remain the principal contraceptive method.

See also

• Nakadashi — the discontinuation of barrier method as a sexual-content category
• Namahame — barrier-free contact terminology
• Ninshin — pregnancy outcomes